Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)P. Joly, Enno Schmidt, Maryam Daneshpazhooh et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 332
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)Luca Borradori, Gang Wang, Nina van Beek et al.|Journal of the European Academy of Dermatology and Venereology|2022Cited by 247
Skin cancer classification via convolutional neural networks: systematic review of studies involving human expertsSarah Haggenmüller, Mildred Sergon, Roman C. Maron et al.|European Journal of Cancer|2021Cited by 246
Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases<sup>§</sup>Michael Hertl, Sonja Wolff‐Franke, Detlef Zillikens et al.|JDDG Journal der Deutschen Dermatologischen Gesellschaft|2008Cited by 137
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibilityXiaolin Liu, John F. Baines, Nina van Beek et al.|Frontiers in Immunology|2023Cited by 25